Investment Summary

Glenwood Private Equity Invests In Olive Young

On December 23, 2020, private equity firm Glenwood Private Equity invested in retailer Olive Young

Investment Highlights
  • This is Glenwood Private Equity’s 1st transaction in the Retail sector.
  • This is Glenwood Private Equity’s 2nd transaction in South Korea.

Investment Summary

Date 2020-12-23
Target Olive Young
Sector Retail
Investor(s) Glenwood Private Equity
Deal Type Stake Purchase

Target

Olive Young

Seoul, South Korea
Olive Young is the first Korean health and beauty retailer with 1,200+ offline stores as well as a fast-growing online platform serving both domestic and global markets. Olive Young was founded in 1999 and is based in Seoul, South Korea.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Glenwood Private Equity

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2014
PE ASSETS 3.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Glenwood Private Equity is a private equity firm specializing in buyouts and corporate carve-outs across South Korea. Prospective transactions include leveraged buyouts, mezzanine and subordinated debt investments, and structured credit strategies that address both equity and financing needs. The Firm's sector expertise spans manufacturing, healthcare, and industrial services. Glenwood Private Equity was founded in 2014 and is headquartered in Seoul.


DEAL STATS #
Overall 2 of 3
Sector: Retail M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
Country: South Korea M&A 2 of 3
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-01 PI Advanced Materials

Seoul, South Korea

PI Advanced Materials (PIAM) is a producer of polyimide film for advanced industries such as display, semiconductors, and electric vehicles. PI Advanced Materials is based in Seoul, South Korea.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-05-03 Invitros

Seoul, South Korea

Invitros is a healthcare company specializing in in-vitro diagnostics, particularly for allergy, tuberculosis and respiratory virus infection tests.

Buy -